A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed to reveal restorative targets. Here we report that human induced pluripotent stem cell (iPSC)-derived dopaminergic neurons (DAn) obtained from healthy individuals or patients harboring LRRK2 PD-causing mutation can create highly complex networks with evident signs of functional maturation over time. Compared to control neuronal networks, LRRK2 PD patients' networks displayed an elevated bursting behavior, in the absence of neurodegeneration. By combining functional calcium imaging, biophysical modeling, and DAn-lineage tracing, we found a decrease in DAn neurite density that triggered overall functional alterations in PD neuronal networks. Our...
Induced pluripotent stem cells (iPSC) offer an unprecedented opportunity to model human disease in r...
Parkinson's disease (PD) is the second most common neurodegenerative disease affecting elderly peopl...
While induced pluripotent stem cell (iPSC) technologies enable the study of inaccessible patient cel...
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed t...
Abstract A deeper understanding of early disease mechanisms occurring in Parkinson’s disease (PD) is...
Some mutations of the LRRK2 gene underlie autosomal dominant form of Parkinson's disease (PD). The G...
Dopaminergic neurons (DAn) were efficiently differentiated from 6 different iPSC lines derived from ...
SummaryMutations in leucine-rich repeat kinase 2 (LRRK2) are the most-common genetic determinants of...
SummaryStudies of Parkinson's disease (PD) have been hindered by lack of access to affected human do...
Summary: The Parkinson disease (PD) genetic LRRK2 gain-of-function mutations may relate to the ER pa...
Parkinson's disease (PD) is a progressive, neurodegenerative disease affecting over 1% of the popula...
Summary: Increasing evidence suggests that neurodevelopmental alterations might contribute to increa...
Parkinson's disease (PD) is an incurable age-linked neurodegenerative disease with characteristic mo...
Parkinson's disease (PD) is a common neurodegenerative disorder, characterised by preferential loss ...
International audienceMutations in PRKN are the most common genetic cause for familial Parkinson’s d...
Induced pluripotent stem cells (iPSC) offer an unprecedented opportunity to model human disease in r...
Parkinson's disease (PD) is the second most common neurodegenerative disease affecting elderly peopl...
While induced pluripotent stem cell (iPSC) technologies enable the study of inaccessible patient cel...
A deeper understanding of early disease mechanisms occurring in Parkinson's disease (PD) is needed t...
Abstract A deeper understanding of early disease mechanisms occurring in Parkinson’s disease (PD) is...
Some mutations of the LRRK2 gene underlie autosomal dominant form of Parkinson's disease (PD). The G...
Dopaminergic neurons (DAn) were efficiently differentiated from 6 different iPSC lines derived from ...
SummaryMutations in leucine-rich repeat kinase 2 (LRRK2) are the most-common genetic determinants of...
SummaryStudies of Parkinson's disease (PD) have been hindered by lack of access to affected human do...
Summary: The Parkinson disease (PD) genetic LRRK2 gain-of-function mutations may relate to the ER pa...
Parkinson's disease (PD) is a progressive, neurodegenerative disease affecting over 1% of the popula...
Summary: Increasing evidence suggests that neurodevelopmental alterations might contribute to increa...
Parkinson's disease (PD) is an incurable age-linked neurodegenerative disease with characteristic mo...
Parkinson's disease (PD) is a common neurodegenerative disorder, characterised by preferential loss ...
International audienceMutations in PRKN are the most common genetic cause for familial Parkinson’s d...
Induced pluripotent stem cells (iPSC) offer an unprecedented opportunity to model human disease in r...
Parkinson's disease (PD) is the second most common neurodegenerative disease affecting elderly peopl...
While induced pluripotent stem cell (iPSC) technologies enable the study of inaccessible patient cel...